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Background: Vascular morbidity and mortality due to cardiovascular disease (CVD) are high after ischemic stroke at
a young age. Data on carotid intima-media thickness (cIMT) as marker of atherosclerosis are scarce for young stroke
populations. In this prospective case–control study, we examined cIMT, the burden of vascular risk factors (RF) and
their associations among young and middle-aged ischemic stroke patients and controls. We aimed to detect clinical
and sub-clinical arterial disease.
Methods: This study was conducted in 150 patients aged 15–60 years and 84 controls free of CVD. We related RF
to ultrasonographic B-mode cIMT-measurements obtained from 12 standardized multiangle measurements in the
common carotid artery (CCA), carotid bifurcation (BIF) and internal carotid artery (ICA).
Results: RF burden was higher among patients than among controls (p < 0.001). In multivariate analyses of all 234
participants, increased cIMT was associated with age in each carotid segment. Incident stroke was associated with
increased ICA-IMT. ICA-IMT increase was associated with a family history of CVD among patients aged 15–44 years,
and with RF at mid-age. The overall cIMT difference between patients and controls was 12% for CCA, 17% for BIF
and 29% for ICA. Further, increased CCA-IMT was associated with male sex and hypertension. Increased BIF-IMT
was associated with dyslipidemia, coronary heart disease and smoking. Increased ICA-IMT was associated with
dyslipidemia and stroke.
Conclusions: Ischemic stroke is associated with increased ICA-IMT, related to a family history of CVD among
patients aged <45 years, and to increasing RF burden with increasing age. Preventive strategies and aggressive
RF treatment are indicated to avoid future cardiovascular events.
Trial registration: NOR-SYS is registered in ClinicalTrials.gov (NCT01597453).
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High rates of recurrent stroke, vascular morbidity and mor-
tality due to cardiovascular disease (CVD) [1-3] clarify the
need to detect and treat vascular risk factors and incipient
atherosclerosis at early stages. Carotid intima-media thick-
ness (cIMT) is a surrogate marker of atherosclerosis [4,5],* Correspondence: annette.fromm@helse-bergen.no
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unless otherwise stated.and ultrasound screening a valuable tool for cardiovascular
risk prediction [6,7]. Nevertheless, cIMT data obtained
from young stroke populations are scarce. We aimed to as-
sess the prevalence of clinical and subclinical carotid artery
atherosclerosis and the impact of vascular risk factors (RF)
among young ischemic stroke patients compared to CVD-
free controls in a case–control study.Methods
The Norwegian Stroke in the Young Study (NOR-SYS) is
a prospective three-generation study with longitudinalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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RF ascertainment by standardized questionnaires with
clinical, laboratory, neuroradiological, cardiological and
complex ultrasonographic data [8]. This analysis contains
data from 150 patients and 84 controls included in
NOR-SYS between September 2010 and June 2012.
Approvals, registrations and consents
NOR-SYS is conducted according to the Declaration of
Helsinki, approved by the Regional Committee for Medical
and Health Research Ethics, Western-Norway (2010/74),
and registered in ClinicalTrials.gov (NCT01597453).
Written informed consent was obtained from all parti-
cipants or their legal representatives.
Subject selection
Patients aged 15–60 years with documented acute ischemic
stroke and residency in Hordaland county, Norway, wereTable 1 Patient and control characteristics
All 15-44 y 45-60
Patients N 150(100)* 45(30)* 105(70
Age (mean) 150 48.5 35.8 54.0
Prior stroke 150 13(8.7) 1(2.2) 12(11.
CHD 150 15(10.0) 1(2.2) 14(13.
PAD 150 8(5.3) 1(2.2) 7(6.7
Family CVD 150 78(52.0) 9(20.0) 69(65.
Diabetes 150 16(10.7) 2(4.4) 14(13.
Hypertension 150 101(67.3) 23(51.1) 78(74.
Dyslipidemia 150 114(76.0) 27(60.0) 87(82.
Smoking 150 104(69.3) 23(51.1) 81(77.
BMI > 25 144 99(68.8) 28(62.2) 71(67.
Alcohol 141
None 9(6.4) 5(11.1) 4(3.8
Low 119(84.4) 37(82.2) 82(78.
High 13(9.2) 2(4.4) 11(10.
Controls N 84(100)* 21(25)* 63(75
Age (mean) 84 49.3 36.6 53.5
Family CVD 84 49(58.3) 9(42.9) 40(63.
Diabetes 84 9(10.7) 1(4.8) 8(12.7
Hypertension 84 16(19.0) 3(14.3) 13(20.
Dyslipidemia 84 12(14.3) 1(4.8) 11(17.
Smoking 84 57(67.9) 12(57.1) 45(71.
BMI > 25 80 45(56.3) 11(52.4) 34(54.
Alcohol 81
None 4(4.9) 0(0.0) 4(6.3
Low 74(91.4) 20(95.2) 54(85.
High 3(3.7) 1(4.8) 2(3.2
Data presented as number (percentage) or mean. *Percentage of total population. y
CVD = Cardiovascular disease; BMI = Body mass index.included. Two patients refused study participation. Seven
patients were excluded; three due to incomplete neuro-
sonographic data set, and four non-Caucasian patients. Pa-
tients’ partners served as controls due to their function as
reference persons for joint offspring in future analyses. Of
123 available partners, 63 (70.8%) females and 21 (61.8%)
males participated. Seven controls with prior cardiovascular
events were excluded from statistical analysis.
Risk factors
Medical history of prior stroke, coronary heart disease
(CHD: myocardial infarction, angina pectoris) and per-
ipheral artery disease (PAD) was defined if diagnosed be-
fore admission or revealed during hospitalization for the
qualifying stroke. Family history of CVD (stroke, CHD
and/or PAD) was considered positive if reported for par-
ents and/or siblings. Hypertension and diabetes mellitus
were defined by diagnosis and/or treatment beforey Females Males Age (p) Sex (p)
)* 49(32.7)* 101(67.3)*
46.3 49.6 <0.001 0.075
4) 6(12.2) 7(6.9) 0.017 0.325
3) 4(8.2) 11(10.9) 0.006 0.589
) 2(4.1) 6(5.9) 0.181 0.617
7) 29(59.2) 49(48.5) <0.001 0.222
3) 7(14.3) 9(8.9) 0.053 0.357
3) 30(61.2) 71(70.3) 0.009 0.282
9) 36(73.5) 78(77.2) 0.007 0.623
1) 28(57.1) 76(75.2) 0.003 0.033
6) 30(61.2) 69(68.3) 0.941 0.542
) 4(8.2) 5(5.0) 0.173 0.476
1) 41(83.7) 78(77.2) 0.947 0.252
5) 1(2.0) 12(11.9) 0.137 0.011
)* 63(75)* 21(25)*
48.8 50.6 <0.001 0.453
5) 35(55.6) 14(66.7) 0.112 0.372
) 5(7.9) 4(19.0) 0.218 0.249
6) 7(11.1) 9(42.9) 0.502 0.012
5) 8(12.7) 4(19.0) 0.066 0.52
4) 40(63.5) 17(81.0) 0.26 0.11
0) 31(49.2) 14(66.7) 0.872 0.147
) 3(4.8) 1(4.8) 0.045 0.989
7) 56(88.9) 18(85.7) 0.399 0.817
) 2(3.2) 1(4.8) 0.79 0.757
= years; CHD = Coronary heart disease; PAD = Peripheral artery disease;
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ing hospitalization for the qualifying stroke (blood
pressure >140/90 mmHg; HbA1c >6.4%). Dyslipidemia
was defined as prior statin use, or when revealed dur-
ing hospitalization (total cholesterol >5.0 mmol/L and/
or low-density lipoprotein (LDL) >3.0 mmol/L and/or
high-density lipoprotein (HDL) <1,0 mmol/L and/or
triglycerides >2.5 mmol/L). Smoking was categorized
as never-smoking or previous/current smoking. Alco-
hol consumption was categorized as never used/low
(0–12 units/week) or high (>12 units/week). Body-
mass index (BMI) was dichotomized as normal or >25.
RF burden was defined as the number of RFs present
(0–10).
Neurosonology and Duplex/Doppler ultrasound
examinations
Extracranial high-resolution sonography of the carotid
arteries was performed with Philips iU22 and 9–3 MHz
linear array transducer. Two patients were examined at
the intensive care unit with a portable Phillips CX50 ultra-
sound system and 12–3 MHz linear array transducer
(both systems Philips Medical Systems, Bothell, WA,
USA). Patients and controls were examined by two sono-
graphers (AF, UWA), which both are trained and certified
for the NOR-SYS duplex sonography research protocol in
collaboration with the Vascular Imaging Centre, University
Medical Centre, Utrecht, The Netherlands.
Data reliability tests
Reproducibility testing of cIMT measurements within
(intra-observer) and between (inter-observer) sonogra-
phers of the research group, and between ultrasoundFigure 1 Risk factor burden. Data referred in percent. P = patients; C = coequipment (inter-equipment) was performed applying
both ultrasound systems. The intra-observer correlation
of sonographers was 0.78-0.98 (mean absolute cIMT dif-
ference 0.02-0.08 mm). The inter-observer correlation of
sonographers was 0.83-0.93 (mean absolute cIMT differ-
ence 0.04-0.11 mm). The inter-equipment correlation for
iU22/CX50 was 0.94 (mean absolute cIMT difference
0.04 mm). These results correlate with previously pub-
lished studies [9-12].
cIMT-measurements
The methods of the cIMT measurements were previ-
ously described [8]. In total 12 far-wall cIMT measure-
ments in the common carotid artery (CCA), the carotid
bifurcation (BIF) and the internal carotid artery (ICA)
were performed in each participant in the end-diastolic
phase of the cardiac cycle, and mean cIMT values were
acquired using Philips QLAB® (Philips Medical Systems,
Bothell, WA, USA). In case of intra-segmental irregularities
or plaques, maximum IMT or plaque thickness were
measured additionally. Maximum segmental IMT values
were used in statistical analysis. IMT values were de-
fined as normal when <0.8 mm, as suspect for arterial
disease when 0.8-0.99 mm [13,14], and as pathological
when ≥1.0 mm [15,16]. Plaques were defined as focal
IMT measurements >1.5 mm [17].
Statistical analyses
To allow for comparison to other studies [18-20], and in
order to assess the influence of age and sex on IMT, our
study population was grouped according to age (younger,
15–44 years; middle-aged, 45–60 years) and sex. Statistical
analysis was performed using R version 3.0.0, and datantrols.
Table 2 Relative change in IMT between patients and controls and mean IMT values
NA Total 15-44 y 45-60 y Females Males Age (p) Sex (p)
CCA
Relative change 12 (4–22) 3 (−9-15) 19 (8–30) 4 (−6-15) 6 (−9-23)
Mean IMT patients 1 0.85 0.63 0.94 0.75 0.89 <0.001 0.003
Mean IMT controls 0 0.73 0.61 0.77 0.7 0.82 <0.001 0.008
BIF
Relative change 17 (2–34) 11 (−9-36) 23 (7–43) 9 (−9-31) 8 (−16-38)
Mean IMT patients 11 1.34 0.84 1.54 1.23 1.39 <0.001 0.079
Mean IMT controls 2 1.12 0.7 1.26 1.04 1.34 <0.001 0.067
ICA
Relative change 29 (12–49) 20 (−2-46) 35 (15–58) 28 (7–53) 1 (−23-31)
Mean IMT patients 30 0.97 0.63 1.1 0.9 1.0 <0.001 0.312
Mean IMT controls 14 0.73 0.47 0.83 0.64 1.06 <0.001 0.021
Data sorted by carotid segment, age group, and sex. Relative change presented in % (CI); IMT presented in mm. CCA = Common carotid artery; BIF = Carotid
bifurcation; ICA = Internal carotid artery; NA = Not available.
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plied when testing for differences between groups. The
unadjusted analysis was conducted applying a univariate
linear regression. Because each individual had two mea-
surements per segment (right/left), a random intercept ap-
proach was used, utilizing the R-function lmer() from the
lme4 package. Dependent variables (cIMT) were skewed
towards low values, and a base 10 log transform was ap-
plied to meet the assumptions of a linear regression.
Hence, the relative change (RC) in cIMT per unit change
in the independent variables (typically 0 or 1) could be ob-
tained. Adjusted analyses were carried out accordingly,
and multivariate logistic regression was applied. Simula-
tions were used to determine the power to detect diffe-
rences between controls and patients for RC ranging fromTable 3 Statistical significance for IMT increase in patients co
Total 15-
CCA
Relative change (unadjusted) 0.005 0.6
Mean IMT (t-test) <0.001 0.5
IMT distribution (Fisher’s exact test) 0.018 0.3
BIF
Relative change (unadjusted) 0.024 0.2
Mean IMT (t-test) 0.006 0.0
IMT distribution (Fisher’s exact test) 0.111 0.4
ICA
Relative change (unadjusted) <0.001 0.0
Mean IMT (t-test) <0.001 0.0
IMT distribution (Fisher’s exact test) <0.001 0.0
Data presented as p-values, sorted by carotid segment, age group, and sex. Statistic
Carotid bifurcation; ICA = Internal carotid artery. Boldface represents statistical signi
population and among middle-aged participants, and as well among the young po1.00 to 1.50 across each carotid segment. Fisher’s exact
test (based on simulations when appropriate) was applied
when comparing tables or rows within tables.
Results
Population demographics are given in Table 1. Of patients,
30.0% were aged 15–44 at study inclusion, and 32.7% were
female. Of 84 controls, 25.0% were aged 15–44 at study
inclusion, and 75.0% were female.
Risk factors
Patients had a higher RF burden than controls in analysis
of the entire study population (p < 0.001) and in subgroup
analyses (age 15–44: p = 0.027; age 45–60: p < 0.001; fe-
males: p < 0.001; males: p = 0.021), visualized in Figure 1.mpared to controls
44 y 45-60 y Females Males
69 <0.001 0.404 0.465
01 <0.001 0.151 0.161
83 0.003 0.418 0.906
99 0.005 0.344 0.544
30 0.005 0.108 0.760
47 0.010 0.202 0.027
79 <0.001 0.008 0.947
03 0.001 0.004 0.741
05 <0.001 0.003 0.155
al significance presented in boldface. CCA = Common carotid artery; BIF =
ficant differences between patients and controls, mainly within the total
pulation and females in the ICA segment.
Figure 2 Segmental cIMT distribution in common carotid
artery, carotid bifurcation and Internal carotid artery. Data
referred in percent. A = Common carotid artery; B = Carotid
bifurcation; C = Internal carotid artery; P = patients; C = controls.
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present among patients. Prior stroke, CHD, family history
of CVD, hypertension, dyslipidemia and smoking were less
prevalent among young than among middle-aged patients,
and smoking and high alcohol consumption were more
common among male than among female patients.
Carotid Intima-media thickness (cIMT)
Values of mean IMT and RC are presented in Table 2 and
significance of all tests applied is shown in Table 3. Mean
IMT values were in all subgroups of patients and controls
lowest in CCA and highest in BIF, and lower in young than
in middle-aged participants. Sex-related differences were
inconsistent. Mean values <0.8 mm were mostly re-
stricted to the young population and to controls. Mean
values ≥1.0 mm were found in BIF in all patient and
control subgroups but the young, and in ICA in middle-
aged patients and male patients and controls. Mean
values ≥1.5 mm were solely found in middle-aged patients.
The RC between patients and controls was in all sub-
groups but males most distinct in ICA (20-35%). Only
middle-aged patients showed IMT increase compared
to controls in CCA (19%) and BIF (23%). Statistical
simulation suggested the need of RC > 12% for CCA,
RC > 22% for BIF, and RC > 25% for ICA to detect
cIMT-differences ≥80% between patients and controls,
which matches our results fairly well.
Details on categorized segmental cIMT distribution are
shown in Figure 2 and Table 3. IMT distribution was
higher than that of controls in all patient subgroups but
males in ICA. IMT distribution was further higher among
middle-aged patients in CCA, and among middle-aged
and male patients in BIF.
Impact of risk factors on cIMT
Table 4 shows analysis of all participants (n = 234). Associ-
ations between RF and IMT increase varied in the diffe-
rent carotid segments, and across age and sex subgroups.
With one exception (ICA in middle-aged participants),
IMT increase was associated with age in all carotid seg-
ments among all subgroups. On the other hand, ICA in
males was the only carotid segment in any subgroup,
where patients’ RF had a stronger impact on IMT increase
than controls’ (p = 0.038).
Discussion
Our study presents cIMT data obtained from young and
middle-aged patients after acute ischemic stroke. Previous
studies on multisegmental RF-cIMT associations related to
Table 4 Associations between vascular risk factors and segmental carotid IMT increase
Participant group Segment Risk factor associations
Entire study population (n = 234) CCA: Age (p < 0.001); male sex (p = 0.023); hypertension (p < 0.001)
BIF: Age (p < 0.001); dyslipidemia (p = 0.018); CHD (p = 0.017); smoking (p = 0.012)
ICA: Age (p < 0.001); dyslipidemia (p = 0.025); prior stroke (p = 0.009)
Age 15–44 years (n = 66) CCA: Age (p = 0.001); hypertension (p = 0.008)
BIF: Age (p < 0.001); hypertension (p = 0.009)
ICA: Age (p = 0.002); family history of CVD (p = 0.039)
Age 45–60 years (n = 168) CCA: Age (p = 0.05); male sex (p = 0.037); hypertension (p = 0.016)
BIF: Age (p = 0.022); dyslipidemia (p = 0.033); smoking (p = 0.016)
ICA: Dyslipidemia (p = 0.022); prior stroke (p = 0.037)
Females (n = 112) CCA: Age (p < 0.001); hypertension (p = 0.031)
BIF: Age (p < 0.001); hypertension (p = 0.049)
ICA: Age (p < 0.001)
Males (n = 122) CCA: Age (p < 0.001); hypertension (p = 0.012)
BIF: Age (p < 0.001); dyslipidemia (p = 0.003); CHD (p = 0.031)
ICA: Age (p < 0.001); dyslipidemia (p = 0.006), PAD (p = 0.028), prior stroke (p = 0.004)
CCA = Common carotid artery; BIF = Carotid bifurcation; ICA = Internal carotid artery.
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[21,22], or did not provide acute phase cIMT data [23]. By
combination of three statistical methods, we identified in-
creased ICA-IMT as distinctly associated with incident
stroke not only among middle-aged adults, as others de-
scribed before [21], but also among young adults aged
15–44 years. Patients aged 15–44 showed a surprising
20% ICA-IMT increase compared to controls. Only a
family history of CVD was found to be associated with
increased ICA-IMT in the younger subgroup, which may
reflect a genetic predisposition [24].
Female patients represent the best-controlled subgroup
in this study. We found an unexpected ICA-IMT increase
of 28% compared to female controls. The increase was
surprisingly high compared to a 4% increase in CCA-IMT,
and a 9% increase in BIF-IMT. In comparison, we found
rather low and constant segmental differences (1-8%) from
controls in male patients, though their control group was
less representative. The only factor related to ICA-IMT in-
crease in females was age. Our results may reflect hormo-
nal influences on the development of atherosclerosis
[25-27]. ICA-IMTamong male patients did not differ from
controls’. However, male controls are insufficiently repre-
sented, what implies limitations for the interpretation of
comparing results among males.
Our study shows a higher RF burden among patients,
but also a high prevalence of RF among presumably
healthy controls. Other studies have reported increasing
risk of vascular events [28] and higher mortality propor-
tional to RF burden [28-30], and recommended early pre-
ventive treatment. Our data strongly support broad
preventive initiatives in families at risk.We found an increasing RF burden with age, and the
three most frequent RF were dyslipidemia (76%), smoking
(69%) and hypertension (67%). This is in accordance with
other studies [19,31]. Our RF rates among patients are,
however, higher than previously reported [31], as e.g. chol-
esterol levels among the Norwegian population remain
high despite improvement during the last decades [32].
Our data further support that cIMT depends on age, sex
and cardiovascular risk [15,33-36]. We found pronounced
cIMT increase in middle-aged patients, which is in line
with a recent young stroke study demonstrating substan-
tial clinical and subclinical atherosclerosis [20].
The major strengths of NOR-SYS are the inclusion of
CVD-free controls and the standardized ultrasound proto-
col. However, our study has limitations. The size of patient
subgroups varies as a consequence of stringent stratifica-
tion of our patient population. Accordingly, controls
(the patients’ partners) are unequally represented. Due
to overall low case numbers, RF associations are in parts
calculated with small sample sizes, which may have af-
fected our results. Further, our data may be valid only for
Caucasians, and may be influenced by the high risk profile
of our population.
We did not account for multiple testing. However, as
we performed approximately 100 tests, Bonferroni cor-
rection (BC) would yield a corrected significance level
of about 0.05/100 = 0.0005, rounded to p < 0.001 in our
study. Hence, associations with p < 0.001 would survive
a BC. BC further reduces the number of type I errors at
the cost of increasing the number of type II errors, and
p-values above 0.0005 may still be indicative of an
association.
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Stroke is associated with increased ICA-IMT already at a
young age, related to a family history of CVD among the
youngest patients and related to RF burden increasing
with age. Also in CVD-free controls, RFs and subclinical
atherosclerosis are prevalent. Our data suggest that vascu-
lar screening reveals established clinical and sub-clinical
arterial disease requiring broad and aggressive treatment
in order to prevent progressing CVD.
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